Findings

What do systematic reviews say?

4,929 questions · 15,213 findings · 2,394 reviews

Sort:Best matchNewestHighest certainty Download CSV

No studies found 15,213 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Intermittent oral diazepam vs intermittent oral clobazam

Recurrent seizure at 18 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral diazepam vs intermittent oral clobazam

Recurrent seizure at 24 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral diazepam vs intermittent oral clobazam

Recurrent seizure at 36 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral diazepam vs intermittent oral clobazam

Recurrent seizure at 48 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral diazepam vs intermittent oral clobazam

Recurrent seizure at 60 months or greater · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral melatonin vs intermittent oral diazepam

Recurrent seizure at 12 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral melatonin vs intermittent oral diazepam

Recurrent seizure at 18 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral melatonin vs intermittent oral diazepam

Recurrent seizure at 24 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral melatonin vs intermittent oral diazepam

Recurrent seizure at 36 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral melatonin vs intermittent oral diazepam

Recurrent seizure at 48 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral melatonin vs intermittent oral diazepam

Recurrent seizure at 60 months or greater · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intermittent oral levetiracetam vs placebo (any antipyretics)

Recurrent seizure at 6 months · children with febrile seizures

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ethosuximide vs lamotrigine

80% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ethosuximide vs lamotrigine

50% or greater reduction in seizure frequency · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ethosuximide vs lamotrigine

Normalisation of the EEG ‐ not reported · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ethosuximide vs valproate

Normalisation of the EEG ‐ not reported · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lamotrigine vs valproate

80% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lamotrigine vs valproate

50% or greater reduction in seizure frequency · absence seizures in children and adolescents

The review found no eligible studies for this question.

1 finding from 1 review

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabidiol (10 mg/kg and 20 mg/kg) plus ASMs vs placebo plus ASMs

Seizure freedom · Lennox‐Gastaut syndrome, any age

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐seizure medications for Lennox‐Gastaut syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Clobazam (low, medium and high doses) plus ASMs vs placebo plus ASMs

Number of participants with ≥ 75% reduction in all seizures · Lennox‐Gastaut syndrome, any age

The review found no eligible studies for this question.

1 finding from 1 review

Anti‐seizure medications for Lennox‐Gastaut syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found